Central nervous system lymphoma is a rare and aggressive form of cancer that develops within the brain, spinal cord, or eyes, requiring specialized care and treatment approaches that differ from other types of cancer.

Understanding Central Nervous System Lymphoma

Central nervous system lymphoma, often called CNS lymphoma, represents a particularly challenging form of cancer that specifically affects the parts of your body responsible for controlling all your functions. This cancer develops in the central nervous system, which includes your brain, spinal cord, the protective layers covering these structures, and sometimes your eyes. Because the eyes sit so close to the brain, they can also be affected by this disease. CNS lymphoma falls under the broader category of non-Hodgkin lymphoma, which is a type of cancer that starts in the lymphatic system.

The lymphatic system plays a crucial role in keeping you healthy. It is part of your immune system and includes a network of vessels and tissues throughout your body that help fight infections and diseases. Within this system are special white blood cells called lymphocytes. In CNS lymphoma, these lymphocytes, particularly a type called B cells, begin to behave abnormally. They start multiplying out of control and form tumors in the central nervous system instead of protecting your body as they should.

There are two main types of CNS lymphoma based on where the cancer begins. Primary CNS lymphoma means the cancer starts in your central nervous system and is not found anywhere else in your body. This is different from secondary CNS lymphoma, which occurs when lymphoma that began somewhere else in your body spreads to your brain, spinal cord, or eyes. The distinction matters because it affects how doctors approach treatment.

How Common Is This Disease

CNS lymphoma is extremely rare. In the United States, only about 1,500 new cases are diagnosed each year. To put this in perspective, its incidence is approximately 0.5 per 100,000 people per year. This rarity means that many general healthcare providers may never encounter a case during their careers, which underscores the importance of seeking care from specialists who have experience with this specific type of cancer.

The disease does not affect everyone equally. Certain groups face higher risks. Men are more likely to develop CNS lymphoma than women. Age also plays a significant role, with people over 65 years old facing increased risk. However, the single biggest risk factor is having a weakened immune system. This helps explain why CNS lymphoma has become more commonly recognized in recent decades, particularly among people living with HIV and AIDS.

Among immunocompromised individuals, such as those with HIV or those taking medications to suppress their immune system after an organ transplant, CNS lymphoma occurs much more frequently. Almost all cases in people with weakened immune systems are associated with the Epstein-Barr virus. Despite these risk factors, it is important to remember that CNS lymphoma can develop in anyone, even those without obvious risk factors.

What Causes CNS Lymphoma

Like many cancers, researchers do not fully understand exactly what triggers a normal lymphocyte to transform into a cancer cell. What they do know is that CNS lymphoma develops when lymphocytes in the central nervous system start behaving abnormally. These cells multiply rapidly and uncontrollably, crowding out healthy cells and forming tumors. In most cases of CNS lymphoma, the problematic cells are B cells, though rarely T cells can be involved.

Almost all primary CNS lymphomas are classified as diffuse large B-cell lymphomas. These belong to the activated B-cell subtype and often have additional genetic changes in pathways that help B cells function, especially in genes called MYD88 and CD79B. These genetic variations help scientists understand how the disease develops and may point toward future treatment approaches.

While the exact trigger remains unknown, scientists have identified several conditions that increase the likelihood of developing this cancer. These risk factors all share a common thread: they involve situations where the immune system is not functioning properly. When your immune system is weakened, it cannot effectively prevent abnormal cells from growing and multiplying.

Who Is at Risk

Certain medical conditions significantly increase the risk of developing CNS lymphoma. People living with HIV and AIDS face elevated risk, especially if they also have an active infection with Epstein-Barr virus. This connection is so strong that in immunosuppression-related primary CNS lymphomas, the Epstein-Barr virus is almost always detected.

Several inherited immune system disorders also raise risk levels. These include Wiskott-Aldrich syndrome, a genetic condition that affects the immune system and causes easy bruising and bleeding; common variable immunodeficiency, which leads to repeated infections due to low antibody levels; and ataxia-telangiectasia, a rare condition affecting movement and coordination along with immune function.

People who have received organ transplants face increased risk as well. This is because they must take immunosuppressant drugs to prevent their body from rejecting the transplanted organ. While these medications are necessary for the transplant to succeed, they also weaken the immune system’s ability to fight off cancer cells. If someone with an organ transplant develops CNS lymphoma, their doctors may need to reduce or stop these immunosuppressant medications as part of their cancer treatment.

Recognizing the Symptoms

The symptoms of CNS lymphoma vary greatly depending on where exactly the tumor forms within your central nervous system. This variability can make the disease difficult to recognize early. For example, if the lymphoma develops in the meninges, which are the protective membranes covering your brain and spinal cord, you might not experience any symptoms at all initially. However, a tumor growing near your eyes typically causes noticeable vision problems. If the cancer affects the part of your brain that controls movement, you might experience weakness or difficulty with coordination.

Many people with CNS lymphoma experience headaches, which can result from increased pressure inside the skull as the tumor grows. These headaches may be accompanied by confusion, making it difficult to think clearly or remember things. Nausea and vomiting are also common, often related to this increased brain pressure.

Neurological symptoms appear frequently. You might notice weakness in your arms, legs, or face. Sometimes this weakness affects only one side of your body, a condition called hemiparesis. Changes in mental state are also common and can include trouble speaking, memory loss, or feeling unusually sluggish. Some people experience personality changes that concern their family members.

Vision problems occur in various forms. You might see double, notice blurry vision, or see floaters drifting across your field of view. Some people have hearing loss or difficulty swallowing, a condition known as dysphagia. Seizures represent another concerning symptom. These may start out infrequently but can become more common over several days or weeks.

In some cases, people lose control over their bowel or bladder function, experiencing urinary and fecal incontinence. This happens when tumors affect the parts of the nervous system that control these functions. Because CNS lymphoma can spread quickly throughout the central nervous system, symptoms may develop or worsen rapidly.

Prevention and Screening

Currently, there are no specific prevention strategies proven to stop CNS lymphoma from developing. Unlike some other cancers where lifestyle changes, vaccinations, or screening programs can reduce risk, CNS lymphoma cannot be prevented through such measures. This is partly because the disease is so rare and partly because its causes remain incompletely understood.

For people at high risk, such as those with HIV or AIDS, maintaining the strongest possible immune system function becomes important. For individuals with HIV, this means adhering to highly active antiretroviral therapy, commonly called HAART. These medications help control the HIV infection and strengthen immune function, which may reduce the risk of developing CNS lymphoma.

No routine screening tests exist for CNS lymphoma in the general population. The disease is too rare to justify widespread screening, and there are no simple tests that can detect it before symptoms appear. Instead, early detection relies on people seeking medical attention when they experience concerning neurological symptoms. If you belong to a high-risk group and notice any symptoms affecting your brain function, vision, coordination, or mental state, it is important to see a doctor promptly.

How the Disease Affects Your Body

Understanding what happens in your body when you have CNS lymphoma helps explain why symptoms occur and why treatment must be approached carefully. The disease causes changes in the normal functioning of your central nervous system through several mechanisms. First, the cancerous lymphocytes multiply uncontrollably, forming masses or tumors. As these tumors grow, they take up space within the confined area of your skull or spinal canal. Because your skull is a rigid structure that cannot expand, any growth inside it creates pressure on your brain.

This increased pressure explains many symptoms. Headaches result from pressure on pain-sensitive structures. Nausea and vomiting occur because pressure affects the parts of your brain that control these functions. Confusion and changes in mental state happen when pressure or tumor location interferes with normal brain activity.

CNS lymphoma can spread throughout your central nervous system by traveling through the cerebrospinal fluid, which is the liquid that surrounds and cushions your brain and spinal cord. This is why the disease can affect multiple areas. In fact, in about 17% of patients with primary CNS lymphoma, the cancer involves the leptomeninges, the membranes surrounding the brain and spinal cord, based on various detection methods.

The tumors interfere with normal brain function in specific ways depending on their location. If a tumor presses on or invades the area of your brain that controls speech, you will have difficulty speaking. If it affects the motor areas that control movement, you will experience weakness or paralysis. When tumors develop near the optic nerves or within the eye itself, vision problems result. The cancer essentially disrupts the normal electrical and chemical signaling that allows your brain and spinal cord to control your body.

Another critical aspect of CNS lymphoma’s effects on your body involves the blood-brain barrier. This is a protective filter that prevents many substances in your bloodstream from entering your brain tissue. While this barrier protects your brain from harmful substances, it also makes treating CNS lymphoma more challenging. Many chemotherapy drugs that work well against lymphoma elsewhere in the body cannot cross this barrier effectively. This is why treatment for CNS lymphoma requires specially selected medications that can penetrate into the central nervous system.

The disease affects not just physical function but also cognitive abilities and personality. Because it directly impacts brain tissue, CNS lymphoma can alter how you think, remember, and behave. These changes can be subtle at first but may become more pronounced as the disease progresses. Family members often notice personality changes before the affected person does, which can be distressing for everyone involved.